YD Bio (YDESW) Non-Current Assets (2024 - 2026)
YD Bio's (YDESW) quarterly Non-Current Assets came in at $4.5 million in Q2 2026, up 0.55% year-over-year from $4.4 million in Q2 2025, and up 8.75% quarter-over-quarter from $4.1 million in Q4 2025.
Analysis
YD Bio (YDESW) Non-Current Assets (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Non-Current Assets for 3 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 0.55% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $16.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.1 million, up 20.99% from the prior year.
- Non-Current Assets was $4.5 million for Q2 2026 at YD Bio, up from $4.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $4.5 million in Q2 2026 and troughed at $3.4 million in Q4 2024.
- A 3-year average of $4.1 million and a median of $4.3 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets advanced 20.99% in 2025 and advanced 0.55% in 2026, its largest moves.
- Over 3 years, Non-Current Assets stood at $3.4 million in 2024, then increased by 20.99% to $4.1 million in 2025, then gained by 8.75% to $4.5 million in 2026.
- The last three Non-Current Assets figures came in at $4.5 million (Q2 2026), $4.1 million (Q4 2025), and $4.4 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn | 564.41 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - | 4.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Dec 31, 2024 | 3.40 Mn |